FDA Clearance Tracker · P020014-S012
CONCEPTUS ESSURE SYSTEM FOR PERMANENT BIRTH CONTROL
Last checked: Nov 20, 2026Latest source record: Jun 15, 2007 (this decision)Source: openFDAMethods & limitations
Decided
Jun 15, 2007
Approved
Time to decision
455 days
Received Mar 17, 2006. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P020014-S012
- Device name
- CONCEPTUS ESSURE SYSTEM FOR PERMANENT BIRTH CONTROL
- Applicant
- Bayer Pharma AG
- Applicant location
- Berlin
- Received
- Mar 17, 2006
- Decided
- Jun 15, 2007
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P020014
Device type
- Device class
- Class III
- Regulation
- 21 CFR 884.5380
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR DESIGN AND MATERIAL CHANGES TO THE MICRO-INSERT, DELIVERY CATHETER, AND INTRODUCER OF THE ESSURE SYSTEM.
Source documents
Other decisions for Bayer Pharma AG
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.